Bridgewater Associates’s ModivCare MODV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,361
Closed -$324K 756
2023
Q4
$324K Sell
7,361
-7,055
-49% -$278K ﹤0.01% 728
2023
Q3
$454K Sell
14,416
-25,935
-64% -$1.01M ﹤0.01% 698
2023
Q2
$1.82M Buy
40,351
+24,913
+161% +$1.48M 0.01% 481
2023
Q1
$1.3M Buy
15,438
+544
+4% +$52.3K 0.01% 525
2022
Q4
$1.34M Sell
14,894
-5,105
-26% -$455K 0.01% 600
2022
Q3
$1.99M Buy
19,999
+2
+0% +$207 0.01% 566
2022
Q2
$1.69M Sell
19,997
-316
-2% -$31.9K 0.01% 711
2022
Q1
$2.34M Buy
20,313
+6,402
+46% +$739K 0.01% 644
2021
Q4
$2.06M Buy
13,911
+604
+5% +$93.4K 0.01% 459
2021
Q3
$2.42M Sell
13,307
-1,134
-8% -$202K 0.01% 410
2021
Q2
$2.46M Buy
+14,441
New +$2.16M 0.02% 456

Other funds holding MODV

Bridgewater Associates's MODV Position: Q1 2024 in Review

Bridgewater Associates sold out of ModivCare (MODV) in Q1 2024, closing a stake of 7,361 shares — an estimated $324K sold.

Bridgewater Associates first reported a position in MODV in Q2 2021 and held it in 11 quarters. The position peaked at $2.46M in Q2 2021. 134 funds tracked by Wall St. Rank hold MODV as of Q1 2024.

  • Bridgewater Associates reported no remaining ModivCare position as of Q1 2024 after selling out during the quarter.
  • Bridgewater Associates sold 7,361 ModivCare shares in Q1 2024, an estimated $324K.
  • Bridgewater Associates first reported a position in ModivCare in Q2 2021 and held it in 11 quarters.
  • Bridgewater Associates's ModivCare position peaked at $2.46M in Q2 2021.
  • 134 funds tracked by Wall St. Rank held ModivCare as of Q1 2024.

Based on Bridgewater Associates's 13F filing for Q1 2024, filed 14 May 2024.